Similar articles

• Survival after bone-marrow transplantation.

  Cwynarski K, Craddock C, Cobbold M, Apperley J, Goldman J. Cwynarski K, et al. Lancet. 2002 Mar 9;359(9309):887-8. doi: 10.1016/S0140-6736(02)07924-2. Lancet. 2002. PMID: 11897306 No abstract available.
• Survival after bone marrow transplantation from cytomegalovirus seropositive sibling donors.

  Nachbaur D, Bonatti H, Oberaigner W, Eibl B, Kropshofer G, Gastl G, Nussbaumer W, Einsele H, Larcher C. Nachbaur D, et al. Lancet. 2001 Oct 6;358(9288):1157-9. doi: 10.1016/S0140-6736(01)06275-4. Lancet. 2001. PMID: 11597674
• Role of immunosuppressive drugs for prevention of graft-v-host disease after human HLA matched bone marrow transplantation.

  Gluckman E, Devergie A, Lokiec F, Traineau R, Cosset JM, Lemercier N, Varrin F, Cavazzana M, de Castro H, Meletis J, et al. Gluckman E, et al. Transplant Proc. 1987 Dec;19(6 Suppl 7):61-5. Transplant Proc. 1987. PMID: 3321648 No abstract available.
• Improved results in marrow transplantation from unrelated donors. Genoa BMT Group.

  Bacigalupo A, Lamparelli T, Barbanti M, Sacchi N, Battista Ferrara G, Pozzi S, Bregante S, Mordini N, Vitale V, Van Lint MT. Bacigalupo A, et al. Haematologica. 1999 Jun;84 Suppl EHA-4:50-2. Haematologica. 1999. PMID: 10907467 Review. No abstract available.
• Cord blood transplantation in thalassemia.

  Issaragrisil S. Issaragrisil S. Blood Cells. 1994;20(2-3):259-62; discussion 263. Blood Cells. 1994. PMID: 7749104 Review.